Brazilian author launches website


Bia Labate is an anthropologist who lives in São Paulo, Brazil. Her main focus of interest is the study of psychoactive substances. Labate is author, co-author and co-editor of six books, with several other books in production. She works as an independent writer, consultant, lecturer and organizer of scientific conferences and cultural events related to the field of drugs, religion and shamanism. She is also a blogger and an anti-prohibitionist activist.

You can check out her new website here 0



Take decisions on drug classification out of UK politician’s hands


Like interest rates, the final decision on the classification of illegal drugs should be free from political influence, say the UK government’s drug advisers

The power to decide the classification of illegal drugs should be taken out of the hands of the home secretary and given to a small, independent committee of experts, according to a proposal being considered by the government’s top advisory body on drug classification. The new group would act rather like the Bank of England’s monetary policy committee, which since May 1997 has decided interest rate levels. Under the proposals discussed today by the Advisory Council on the Misuse of Drugs, a “classification committee” of scientists, social scientists and experts in the drug field would decide which class a drug should occupy based on evidence of the harm it causes to individuals and society.

In a separate development, the ACMD’s chair Prof David Nutt told the meeting that the advisory group would be undertaking a review of the classification of psychedelic drugs including LSD, psilocybin (”magic mushrooms”) and possibly the currently legal drug salvia. He said that the ACMD’s technical sub-committee had decided that the classification of LSD and psilocybin as class A drugs was due for a review. The committee had not looked at the evidence for harm caused by these substances for some time, he said. Sir Gabriel Horn, a professor of behavioural neuroscience at Cambridge University, told the committee that the whole drug classification system needed to be reformed because national drug use has changed so much since the 1971 Misuse of Drugs Act was brought in.

The amount of cocaine use is now 30 times higher and there are up to 80 times as many deaths from injecting drugs. Horn advocated taking decisions about drug classification out of the hands of politicians to avoid the kind of political row that has accompanied the government’s decision to move cannabis from class C to class B. “It appeared that a decision had been taken at the very highest levels in government that cannabis should be classified B before the advice had been received in the report from the [ACMD],” he said. “I think that is a very unwise step. I think it is a dangerous step.”

He said interest rate decisions used to be embroiled in similar political wrangling before the government devolved decision-making to the Bank of England. “There used to be in days gone by huge controversy as to whether the chancellor of the exchequer should go one way or the other … Now we don’t have that.” Horn was presenting a report from an Academy of Medical Sciences committee, which he chaired, on the harm caused by drugs, although he said the proposals about a classification committee were a “personal view”.

Former shadow home secretary David Davis MP was scathing about the idea. “I hope his level of analysis of his own subject is better than his level of analysis of the monetary history of the country,” he told the Guardian, referring to the monetary policy committee’s failure to foresee the current financial crisis. Davis said that the issues surrounding drug classification were too complex for any scientific committee to tackle without political input. “They relate to social issues and issues of judgement such as the relationship between certain drugs and crime, the impact of classification on the behaviour of the police and the behaviour of the population – all of which are not susceptible to the laws of physics or even the laws of biology,” he said.

He added that the proposal would not succeed in taking the politics out of drug policy. “In truth the political battle would move to who was on the committee,” he said. Horn said that members of the committee should not be appointed by the home secretary, as is the case with the ACMD, but by “trusted” institutions such as the Royal Society and the British Academy in order to free the committee from political influence.

source = http://www.guardian.co.uk/science/2008/nov/25/illegal-drugs-classification#history-byline



feed_back


happiness is only real when shared…

thank you all for making ‘Psychedelic Medicine News‘ real.

3.000 unique visits this week. Getting close to 11.000 on November 2008, shortly. this is it. we are making it happen. =)



The therapeutic potential of substance abuse treatment with Ayahuasca


Investigator:Dipl. Psych Anya Loizaga-Velder, University of Heidelberg, Germany
Contact: Anya Loizaga Velder  
This qualitative study will involve interviewing 10 health professionals who work with ayahuasca as an adjunct for substance abuse treatment in order to gain a deeper understanding about the therapeutic process of ayahuasca-assisted therapy for addiction, as well as identifying major differences in conceptualization and practice of the addiction treatments. Loizaga-Velder will also interview five health professionals who are working or have worked with other psychedelics as adjuncts to treatment of addiction. A follow up study of 10 subjects who have participated in ayahuasca intervention for addiction will also be conducted. The research seeks to examine how ayahuasca is used in different contexts of addiction treatment and the institutional, psychological and social conditions that provide for a successful treatment outcome for ayahuasca-assisted therapy for addiction. This research is part of the Ritual Dynamics and Salutogenesis project ( RISA); www.risa.uni-hd.de  .



Czech Lower House Approves Lower Marijuana Penalties


from Drug War Chronicle, Issue #560, 11/14/08
The Czech lower house of parliament Tuesday approved changes in the country’s penal code that distinguish between hard and soft drugs and make possession of small amounts of marijuana only a low-level offense. The reform must now pass the upper chamber and be signed by the president of the republic.

Under current Czech law, the production and sale of any sort of illicit drug is punishable by five to fifteen years in prison. Under the reforms approved by the lower house, while those possessing more than personal use amounts of most drugs would face up to two years in prison, those found possessing large amounts of marijuana would face up to one year in prison and those caught growing larger amounts of pot would face up to six months.

The Czech government has already issued a draft decree effectively decriminalizing the possession of small amounts of drugs, including up to 20 joints or three pot plants, 25 magic mushrooms, 0.3 grams of Ecstasy and morphine, 0.2 grams of heroin, a half-gram of cocaine, and 0.005 grams of LSD. But that draft is not yet binding on the courts.

Passage of the reform measure didn’t come without clashes among junior members of the ruling coalition. The Greens proposed the complete legalization of marijuana use and production for adults, while the Christian Democrats argued against any differentiation between soft and hard drugs. Both those measures were rejected.



Call for papers: “CANNABIS & PHILOSOPHY: WHAT WERE WE JUST TALKING ABOUT?”


Dale Jacquette - Senior Professorial Chair in Theoretical Philosophy
University of Bern, Switzerland

If you like the description below, don’t hesitate to send in your paper. Be a seeder!

There are countless philosophically interesting issues related to cannabis use. Suggestions for topics include but are by no means limited to: cannabis gourmandise; phenomenology and epistemology of cannabis intoxication; distinction between substance use and substance abuse; morality of illegal substance ingestion; civil disobedience and cannabis use; medicinal marijuana and the morality of legal sanctions against medically prescribed usage; related health aspects of cannabis; definitions of ’soft’ and ‘hard’ drugs; whether cannabis is a gateway substance to harder substances; cannabis-influenced aesthetics in art and music; political aspects of cannabis legalization and decriminalization movements; medical and psychological effects of cannabis use, short- and long-term; social implications of cannabis prohibition; relativism and cannabis-induced alterations of perception; memory and cannabis use; impact of cannabis on popular culture; cannabis and nineteenth century literature; globalism and worldwide cannabis cultivation practices; cannabis tourism; legal and social dimensions of home cultivation; cannabis and philosophical insight; cannabis  and the critical outlook in philosophy; enhancement of pleasures using recreational drugs.

Contributors to the volume will include philosophers, academics outside of philosophy in fields related to the volume’s themes, and knowledgeable experts in the industry and production of cannabis and paraphernalia. There is no presumption that by writing for this volume a contributor implies either personal cannabis ingestion or an endorsement of cannabis use by others. The volume introduction will contain explicit disclaimers to this effect, and individual contributors are welcome if they choose also to emphasize this fact in their own specific cases. Critics of cannabis are especially invited to contribute. We will be treating an important theme in an academic fashion like any other of social importance, although we expect the collection also to feature a certain amount of fun and mature good humor about marijuana use; contributors are accordingly encouraged if they choose to relate personal anecdotes and impressions if any of their own or
acquaintances’ experience with cannabis.

Guidelines for Contributions:

Abstract of paper (approx. 250 words) submission deadline:  *December 1, 2008
Acceptances will be issued December 15, 2008
Submission deadline for completed papers will be in the Summer 2009
Final papers should be approximately 4000-5000 words
Abstracts should be submitted by e-mail to dale.jacquette@philo.unibe.ch.
Please contact Prof. Jacquette at the above email address if you have any questions about the book.  Other proposals for series titles are also welcome; please direct those to Fritz Allhoff at fritz.allhoff@wmich.edu

Messages to the list are archived at http://listserv.liv.ac.uk/archives/philos-l.html.
Prolonged discussions should be moved to chora: enrol via http://listserv.liv.ac.uk/archives/chora.html. Other philosophical resources on the Web can be found at http://www.liv.ac.uk/pal.



CNN’s Dr. Sanjay Gupta Reports on MDMA/PTSD Research


On Thursday, Nov. 13, CNN’s Dr. Sanjay Gupta reported on the results of MAPS’ US MDMA/PTSD study, conducted by Dr. Michael and Annie Mithoefer.

The url of the report is: Here  

The occasion of the CNN piece was a poster presentation by Dr. Mithoefer at the 24th annual meeting of the International Society of Traumatic Stress Studies, the largest organization of researchers and therapists interested in PTSD.

A visual of a brain under the influence of MDMA positively sparkled due to the release of serotonin.  This is particularly remarkable to those of us who recall prior visuals of the brains of MDMA users shown on MTV and Oprah with holes throughout supposedly caused by MDMA,  and NIDA’s image of the brain of an MDMA user which seemed to show dead areas and areas of substantially reduced functionality. It’s our understanding that reports on information presented at scientific conferences do not compromise the ability to have a subsequent paper accepted for publication in a peer-reviewed journal.

Rick Doblin | MAPS



First Research into psychedelics in the UK in over 40 years!


Beckley Foundation’s collaborative MRI study into the neurological effects of psilocybin has received full ethical approvals!

cap

They are now waiting on R & D approval before embarking on the first research into psychedelics in the UK in over 40 years, which should be underway by Christmas. This study will provide new insights on
1) how the changes in cerebral blood flow brought about by psilocybin are correlated with the substance’s subjective effects,
2) how psilocybin affects regional activation, and
3) the effect on affective responses to emotionally significant stimuli. In so doing, it will help inform the psychotherapeutic applications for this powerful substance.

This is a pioneering study into the effects of LSD on human subjects, the first to get approvals since prohibition ended all such research, is progressing well and we are in the process of developing new creativity measures, suitable for assessing the changes in cognitive functioning that might potentiate creativity. They will also be assessing changes in hemispheric activity and seeing how this might be influenced by LSD.

The collaborative investigation using fMRI into the effects of LSD on cerebral circulation is currently waiting to hear from the ethical approvals board.

Dr. Peter Gasser’s study on LSD as a palliative treatment to ease pain and death-related anxiety among the terminally ill is underway and showing early promise.

For more information contact:

Amanda, Lady Neidpath
The Beckley Foundation
Beckley Park - Oxford
Tel +44 1865351209
Tel +44 1865351019
www.beckleyfoundation.org



Bad Behavior has blocked 284 access attempts in the last 7 days.